PULMONARY NODULAR LYMPHOID HYPERPLASIA

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting PULMONARY NODULAR LYMPHOID HYPERPLASIA:

# Drug Count
0 PREDNISONE 4
1 RITUXIMAB 2
2 BENZONATATE 1
3 CARBOPLATIN 1
4 CISPLATIN 1
5 ETANERCEPT 1
6 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 1
7 FUROSEMIDE 1
8 GEMCITABINE 1
9 GEMCITABINE HYDROCHLORIDE 1
See all common drugs associated with PULMONARY NODULAR LYMPHOID HYPERPLASIA

PULMONARY NODULAR LYMPHOID HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SENNOSIDES, DOCUSATE SODIUM 1 0.0250
1 POSACONAZOLE 1 0.0001
2 BENZONATATE 1 0.0001
3 ZOLEDRONIC ACID 1 0.0000
4 GEMCITABINE HYDROCHLORIDE 1 0.0000
5 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 1 0.0000
6 CISPLATIN 1 0.0000
7 RITUXIMAB 2 0.0000
8 PEMBROLIZUMAB 1 0.0000
9 SACUBITRIL AND VALSARTAN 1 0.0000
See all drugs enriched for association with PULMONARY NODULAR LYMPHOID HYPERPLASIA